Compare IRTC & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | KBH |
|---|---|---|
| Founded | 2006 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 2016 | 1994 |
| Metric | IRTC | KBH |
|---|---|---|
| Price | $118.89 | $62.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | ★ $197.92 | $56.17 |
| AVG Volume (30 Days) | 519.0K | ★ 1.3M |
| Earning Date | 04-30-2026 | 03-24-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | $747,138,000.00 | ★ $4,547,002,000.00 |
| Revenue This Year | $19.60 | N/A |
| Revenue Next Year | $15.94 | $9.23 |
| P/E Ratio | ★ N/A | $116.81 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.85 | $44.03 |
| 52 Week High | $210.01 | $68.71 |
| Indicator | IRTC | KBH |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 71.31 |
| Support Level | $111.37 | $60.92 |
| Resistance Level | $121.88 | $63.24 |
| Average True Range (ATR) | 5.56 | 2.39 |
| MACD | 1.26 | 0.97 |
| Stochastic Oscillator | 85.36 | 86.40 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.